Pharmacological profiling an abundantly expressed schistosome serotonergic GPCR identifies nuciferine as a potent antagonist

Pharmacological profiling an abundantly expressed schistosome serotonergic GPCR identifies nuciferine as a potent antagonist

5-hydroxytryptamine (5-HT) is a key regulator of muscle contraction in parasitic flatworms. In Schistosoma mansoni, the myoexcitatory action of 5-HT is effected through activation of a serotonergic GPCR (Sm.5HTRL), prioritizing pharmacological characterization of this target for anthelmintic drug di...

Full description

Bibliographic Details
Main Authors:	John D. Chan, Sreemoyee Acharya, Timothy A. Day, Jonathan S. Marchant
Format:	Article
Language:	English
Published:	Elsevier 2016-12-01
Series:	International Journal for Parasitology: Drugs and Drug Resistance
Subjects:	Natural products Schistosomiasis 5-HT Methoxyisoquinoline
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211320716300379

Similar Items

Kinetic profiling an abundantly expressed planarian serotonergic GPCR identifies bromocriptine as a perdurant antagonist
by: John D. Chan, et al.
Published: (2016-12-01)

The host-parasite relationship of schistosomes in mice
by: Mubarak, Jamil Salim
Published: (1996)

Induction of immunity in mice by the radiation attenuated schistosome vaccine
by: Anderson, Sonia
Published: (1996)

Schistosome Infections: An Indian Perspective
by: Arunava Kali
Published: (2015-02-01)

Comparison of non-schistosomal colorectal cancer and schistosomal colorectal cancer
by: Weixia Wang, et al.
Published: (2020-07-01)

Schistosome ABC multidrug transporters: From pharmacology to physiology
by: Robert M. Greenberg
Published: (2014-12-01)

From behavioral context to receptors: serotonergic modulatory pathways in the IC
by: Laura M Hurley, et al.
Published: (2012-09-01)

Schistosomal hepatopathy
by: Zilton A Andrade
Published: (2004-08-01)

Study on pathogenesis of schistosomal liver fibrosis
by: ZHAO Lei
Published: (2015-03-01)

Schistosomal Cervical Myelopathy
by: Ronald Farias, et al.
Published: (2018-06-01)

Deciphering the glycogenome of schistosomes
by: Megan Lee Mickum, et al.
Published: (2014-08-01)

Myofibroblasts in Schistosomal Portal Fibrosis of Man
by: Andrade Zilton A, et al.
Published: (1999-01-01)

Acute Schistosomal Colitis Preceded by Katayama Syndrome
by: Sarra Osman Elamin Bushara, et al.
Published: (2017-04-01)

Schistosome-Associated Pulmonary Arterial Hypertension: A Review Emphasizing Pathogenesis
by: Teresa Cristina Abreu Ferrari, et al.
Published: (2021-10-01)

Schistosomal Myeloradiculopathy - A case report
by: Maria Aparecida da Silva, et al.
Published: (2019-05-01)

Immune Evasion Strategies of Schistosomes
by: Jacob R. Hambrook, et al.
Published: (2021-02-01)

Differential Regulation of Granuloma Size and Hepatic Fibrosis in Schistosome Infections
by: Allen W Cheever
Published: (1997-09-01)

Schistosomal myeloradiculopathy due to Schistosoma mansoni: report on 23 cases
by: Vandack Nobre, et al.
Published: (2001-09-01)

Quality of Life Assessment Among Patients Living With Hepatosplenic Schistosomiasis and Schistosomal Myeloradiculopathy
by: Silvana Júnia Roriz, et al.
Published: (2021-06-01)

Role of MicroRNAs in Schistosomes and Schistosomiasis
by: Lihui eZhu, et al.
Published: (2014-11-01)

Schistosomes and snails: a molecular encounter
by: Matty eKnight, et al.
Published: (2014-07-01)

Migräne und das serotonerge System
by: Herzog, Anna Laura
Published: (2008)

Schistosome TRP channels: An appraisal
by: Swarna Bais, et al.
Published: (2020-08-01)

Hyperplasia of elastic tissue in hepatic schistosomal fibrosis
by: Zilton A. Andrade, et al.
Published: (1991-12-01)

Dissecting the schistosome cloak
by: Carolyn E Adler
Published: (2018-04-01)

Clinical-epidemiologic profile of the schistosomal myeloradiculopathy in Pernambuco, Brazil
by: Karina Conceição GM de Araújo, et al.
Published: (2010-07-01)

Natural Products as Leads in Schistosome Drug Discovery
by: Bruno J. Neves, et al.
Published: (2015-01-01)

Schistosoma mansoni : localisation of schistosome antigens using antibodies raised against adult worm tegument membranes
by: Riengrojpitak, S.
Published: (1987)

Serotonergic modulation of nicotine-induced kinetic tremor in mice
by: Naofumi Kunisawa, et al.
Published: (2017-06-01)

TRP channels in schistosomes
by: Swarna Bais, et al.
Published: (2016-12-01)

Repair of schistosomal intestinal vascular lesions after curative treatment
by: Luciana Silva, et al.
Published: (1995-06-01)

Gene Function in Schistosomes: Recent Advances Towards a Cure
by: Arnon Dias Jurberg, et al.
Published: (2015-04-01)

Serotonergic Regulation of Corticoamygdalar Neurons in the Mouse Prelimbic Cortex
by: Daniel Avesar, et al.
Published: (2018-08-01)

Remodeling of hepatic vascular changes after specific chemotherapy of schistosomal periportal fibrosis
by: Zilton A Andrade, et al.
Published: (2006-10-01)

Bilateral paravertebral block in advanced schistosomal liver disease: A prospective study
by: Abou Zeid Haitham, et al.
Published: (2004-01-01)

Schistosome Vaccines for Domestic Animals
by: Hong You, et al.
Published: (2018-06-01)

Serotonergic neurons in the ventral nerve cord of Chilopoda – a mandibulate pattern of individually identifiable neurons
by: Andy Sombke, et al.
Published: (2017-07-01)

Family occurrence of schistosomal hepatosplenomegaly and maternal effect
by: José Tavares-Neto, et al.
Published: (1989-03-01)

Experimental pulmonary schistosomiasis: lack of morphological evidence of modulation in schistosomal pulmonary granulomas Esquistossomose pulmonar experimental: falta de evidência morfológica de modulação nos granulomas esquistosomóticos pulmonares
by: Maura R. F. Souza Vidal, et al.
Published: (1993-10-01)

A Review of Nanotechnology for Targeted Anti-schistosomal Therapy
by: Tayo Alex Adekiya, et al.
Published: (2020-01-01)